The evolving paradigm of second-line hormonal therapy options for castration-resistant prostate cancer

Kevin D. Courtney, Mary Ellen Taplin

Research output: Contribution to journalReview article

19 Scopus citations

Fingerprint Dive into the research topics of 'The evolving paradigm of second-line hormonal therapy options for castration-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences